Financhill
Back

Dyne Therapeutics Stock Predictions

Dyne Therapeutics Stock Forecast

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 11.5% based on the past 4 years of stock performance.
  • Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Dyne Therapeutics Stock Undervalued?
    The current Dyne Therapeutics [DYN] share price is $24.76. The Score for DYN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Dyne Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 11.5% based on the past 4 years of stock performance.

Dyne Therapeutics Stock Rating

Sell
24
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics overpriced?

  • Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Dyne Therapeutics Stock Price History

Is DYN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dyne-tx.com

52-Week Data

52-Week High:
47.45
52-Week Low:
15.22

Prediction Charts

Market Cap:
2.5B
Price in USD:
24.76
Volume:
1.1M
Beta:
1.16

Technical Analysis

SMA50:
28.09
SMA100:
32.68
SMA200:
32.54
52-Wk Change:
67.64%

Stock Predictions

  • Is Dyne Therapeutics stock public?
    Yes, Dyne Therapeutics is a publicly traded company.
  • What is the Dyne Therapeutics stock quote today?
    The Dyne Therapeutics stock price is 24.76 USD today.
  • How to buy Dyne Therapeutics stock online?
    You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 26.42 25.73 26.57 25.08
Dec-16 25.85 26.10 26.28 25.47
Dec-17 26.08 26.16 26.54 25.27
Dec-18 26.69 24.53 26.69 24.31
Dec-19 24.63 24.30 24.63 23.76
Dec-20 23.91 23.99 24.90 23.65
Dec-23 23.79 23.91 24.24 23.31
Dec-24 23.96 23.97 24.15 23.43
Dec-26 23.73 24.47 24.57 23.48
Dec-27 24.20 23.72 24.88 23.40
Dec-30 23.39 23.65 24.00 23.05
Dec-31 23.88 23.56 24.14 23.35
Jan-2 23.87 25.46 26.22 23.74
Jan-3 25.59 24.76 26.18 24.25

Dyne Therapeutics Earnings

Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dyne Therapeutics Forecast Revenue Growth

Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.14 per share.

* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.